Home > Our Partners > Synthego
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s platform technologies vertically integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance basic research, target validation, and clinical trials.
With its technologies cited in hundreds of peer-reviewed publications and utilized by thousands of commercial and academic researchers and therapeutic drug developers, Synthego is at the forefront of innovation enabling the next generation of medicines by delivering genome editing at an unprecedented scale.
Eliminate experimental variability. High-quality sgRNA combined with automated and optimized CRISPR protocols deliver the newest gold standard in CRISPR cells.
Platforms leverage engineering principles to enable the industrialization of reagent manufacturing and cell engineering.
Platforms are built to learn from the successful feedback from design, synthesis, and CRISPR editing for higher predictability of project success.
Synthego offers access to an ecosystem of synthetic RNA solutions for CRISPR genome engineering.
Unprecedented access to CRISPR genome engineering. Your edit, your cell with guaranteed results.
Design top-scoring guide RNAs for gene knockout and perform rapid accurate analysis of Sanger sequences.
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
Or give us a call at:
